Corrigendum: HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas (Oncogene (2009) 28 (876-885) DOI: 10.1038/onc.2008.438);HAND1 gene expression is negatively regulated by the high mobility group A1 proteins and is drastically reduced in human thyroid carcinomas

Oncogene

Volumn 28, Issue 6, 2009, Pages 876-885

  Hoyos, J Martinez ^a,b   Ferraro, A ^b   Sacchetti, S ^b   Keller, S ^a,b   De Martino, I ^a,b   Borbone, E ^b   Pallante, P ^b   Fedele, M ^a   Montanaro, D ^b   Esposito, F ^a   Cserjesi, P ^c   Chiariotti, L ^a,b   Troncone, G ^a   Fusco, A ^a,b,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c Tulane University   (United States)

^d Facoltà di Medicina e Chirurgia di Napoli   (Italy)

Author keywords

ES cells; HAND1; HMGA1; Knockout mice; Thyroid carcinomas

Indexed keywords

HAND1 PROTEIN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ANAPLASTIC THYROID CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CLONOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; FOLLICULAR THYROID ADENOMA; FOLLICULAR THYROID CARCINOMA; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GIANT CELL; HAND1 GENE; HEART DEVELOPMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METHYLATION; MOUSE; NONHUMAN; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; THYROID CARCINOMA; THYROID GLAND; TROPHOBLAST; TUMOR GROWTH; UPREGULATION;

MUS;

EID: 60149097887     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.137     Document Type: Erratum

References (21)

1. Baldassarre G, Fedele M, Battista S. (2001). Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-Cgene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci USA 98: 7970-7975.
2. Battista S, Pentimalli F, Baldassarre G, Fedele M, Fidanza V, Croce CM et al. (2003). Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J 17: 1496-1498.
3. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. (2002). Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21: 2971-2980.
4. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F et al. (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 5: 2439-2446.
5. Cross JC, Flannery ML, Blanar MA, Steingrimsson E, Jenkins NA, Copeland NG et al. (1995). Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development 121: 2513-2523.
6. Cserjesi P, Brown D, Lyons GE, Olson EN. (1995). Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev Biol 170: 664-678.
7. Donato G, Martinez Hoyos J, Amorosi A, Maltese L, Lavano A, Volpentesta G et al. (2004). High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncol Rep 6: 1209-1213.
8. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. (2001). Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22: 1583-1591.
9. Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJ, Visone R et al. (2006). Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 66: 2536-2543.
10. Fusco A, Fedele M. (2007). Roles of the HMGA proteins in cancer. Nat Rev Cancer 7: 899-910.
11. Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S et al. (2004). Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 23: 8705-8710.
12. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. (2002). Identification of silencing of nine genes in human gastric cancers. Cancer Res 62: 6645-6650.
13. Knofler M, Meinhardt G, Bauer S, Loregger T, Vasicek R, Bloor DJ et al. (2002). Human Hand1 basic helix-loop-helix (bHLH) protein: extra-embryonic expression pattern, interaction partners and identification of its transcriptional repressor domains. Biochem J 361: 641-651.
14. Kondo T, Ezzat S, Asa S. (2006). Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nature Rev Cancer 6: 292-306.
15. Martinez Hoyos J, Fedele M, Battista S, Pentimalli F, Kruhoffer M, Arra C et al. (2004). Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res 64: 5728-5735.
16. Pallante P, Berlingieri MT, Troncone G. (2005). UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 93: 464-471.
17. Reeves R. (2001). Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277: 63-81.
18. Riley P, Anson-Cartwright L, Cross JC. (1998). The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18: 271-275.
19. Ritter O, Haase H, Schulte HD, Lange PE, Morano I. (1999). Remodeling of the hypertrophied human myocardium by cardiac bHLH transcription factors. J Cell Biochem 74: 551-561.
20. Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW et al. (2004). Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci 95: 741-744.
21. Thanos D, Maniatis T. (1995). Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.